drugset / Trial / NCT03646396
Effect of Sofosbuvir-daclatasuvir on Angiogenesis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The study aimed at study of the Effect of Daclatasvir Plus Sofosbuvir on Angiogenesis in Egyptian Patients With Chronic HCV Infection
Timeline
- Start
- 2018-08-01
- Primary completion
- 2025-08
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Daclatasvir | Small molecule | — | — |
| Subject | Sofosbuvir | Small molecule | — | — |